Sripathi M. Sureban - Concepedia

Concepedia

Author

Sripathi M. Sureban

University of Oklahoma Health Sciences Center ORCID

Also Known As

J Schulzke, S M Sureban, S.M. Sureban, Shripathi Sureban, Sripathi M Sureban, Sripathi M. SUREBAN, Sripathi M. Sureban, Sripathi Sureban, SripathiM Sureban, Sureban, S.M.

135

Publications

3.3K

Citations

32

H-Index

64

Concepts

All Affiliations

University of Oklahoma Health Sciences Center Coare Biotechnology (United States)Oklahoma State University Oklahoma City Washington University in St. Louis University of Kansas Medical Center

SM

About

Sripathi M. Sureban is an author at University of Oklahoma Health Sciences Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.4K
2	Cell Biology	16	18	1.4K
3	Health Sciences	4	4	290
4	Natural Sciences	1	1	140
5	Biomolecular Engineering	1	1	34

Sripathi M. Sureban

×

39

Publications

3.3K

Citations

32

H-Index

	Year	Citations
Identification of a Novel Putative Gastrointestinal Stem Cell and Adenoma Stem Cell Marker, Doublecortin and CaM Kinase-Like-1, Following Radiation Injury and in Adenomatous Polyposis Coli/Multiple Intestinal Neoplasia Mice Randal May, Terrence E. Riehl, Clayton R. Hunt, Stem Cells	2007	275
DCAMKL-1 Regulates Epithelial–Mesenchymal Transition in Human Pancreatic Cells through a <i>miR-200a</i> –Dependent Mechanism Sripathi M. Sureban, Randal May, Stan Lightfoot, Cancer Research	2011	223
Knockdown of RNA Binding Protein Musashi-1 Leads to Tumor Regression In Vivo Sripathi M. Sureban, Randal May, Robert George, Gastroenterology Tumor RegressionSystems BiologyMedicineTumor SuppressorGene Expression	2008	173
Doublecortin and CaM Kinase-like-1 and Leucine-Rich-Repeat-Containing G-Protein-Coupled Receptor Mark Quiescent and Cycling Intestinal Stem Cells, Respectively Randal May, Sripathi M. Sureban, Nguyet M. Hoang, Stem Cells	2009	158
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism Sripathi M. Sureban, Randal May, Fadee Mondalek, Journal of Nanobiotechnology	2011	154
Diphenyl Difluoroketone: A Curcumin Derivative with Potent <i>In vivo</i> Anticancer Activity Dharmalingam Subramaniam, Randal May, Sripathi M. Sureban, Cancer Research	2008	149
DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer Sripathi M. Sureban, Randal May, Dongfeng Qu, PLoS ONE	2013	146
Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe Sripathi M. Sureban, Satish Ramalingam, Gopalan Natarajan, Oncogene Cell RegulationCell DivisionMedicineNatural SciencesMolecular Biology	2008	140
Selective Blockade of DCAMKL-1 Results in Tumor Growth Arrest by a Let-7a MicroRNA-Dependent Mechanism Sripathi M. Sureban, Randal May, Satish Ramalingam, Gastroenterology Cancer ResearchSelective BlockadeMedicineImmunologyImmune Checkpoint Inhibitor	2009	122
RETRACTED ARTICLE: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells Parthasarathy Chandrakesan, Jiannan Yao, Dongfeng Qu, Molecular Cancer	2017	122

Page 1